Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Bollard

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Vaccine|February 3, 2009
De novo T-lymphocyte responses against baculovirus-derived recombinant influenzavirus hemagglutinin generated by a naive umbilical cord blood model of dendritic cell vaccinationAmar Safdar, William K Decker, Sufang Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 5, 2014
Broadly-specific cytotoxic T cells targeting multiple HIV antigens are expanded from HIV+ patients: implications for immunotherapySharon Lam, Julia Sung, Conrad Cruz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2015
Matched related and unrelated donor hematopoietic stem cell transplantation for DOCK8 deficiencyJennifer Cuellar-Rodriguez, Alexandra F Freeman, Jennifer Grossman, et al.
Blood|May 24, 2003
Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responsesPersis J Amrolia, Giada Muccioli-Casadei, Eric Yvon, et al.
Haematologica|May 2, 2016
Role of the tumor microenvironment in mature B-cell lymphoid malignanciesNathan H Fowler, Chan Yoon Cheah, Randy D Gascoyne, et al.
Frontiers in Immunology|February 5, 2026
Cancer immunotherapy insights: key takeaways from the ADSCC bone marrow and cellular therapy congress 2024Gisela Maria Suárez Formigo, Zaima Mazorra, Cinthia Olexen, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 31, 2013
The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantationRohtesh S Mehta, Antonio Di Stasi, Borje S Andersson, et al.
Cytotherapy|October 8, 2013
Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood engraftmentSimon N Robinson, Michael W Thomas, Paul J Simmons, et al.
British Journal of Haematology|March 16, 2017
Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myelomaNina Shah, Li Li, Jessica McCarty, et al.
Journal for Immunotherapy of Cancer|June 20, 2020
Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancerAnanth Annapragada, Andrew Sikora, Catherine Bollard, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Vaccine|February 3, 2009
De novo T-lymphocyte responses against baculovirus-derived recombinant influenzavirus hemagglutinin generated by a naive umbilical cord blood model of dendritic cell vaccinationAmar Safdar, William K Decker, Sufang Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 5, 2014
Broadly-specific cytotoxic T cells targeting multiple HIV antigens are expanded from HIV+ patients: implications for immunotherapySharon Lam, Julia Sung, Conrad Cruz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2015
Matched related and unrelated donor hematopoietic stem cell transplantation for DOCK8 deficiencyJennifer Cuellar-Rodriguez, Alexandra F Freeman, Jennifer Grossman, et al.
Blood|May 24, 2003
Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responsesPersis J Amrolia, Giada Muccioli-Casadei, Eric Yvon, et al.
Haematologica|May 2, 2016
Role of the tumor microenvironment in mature B-cell lymphoid malignanciesNathan H Fowler, Chan Yoon Cheah, Randy D Gascoyne, et al.
Frontiers in Immunology|February 5, 2026
Cancer immunotherapy insights: key takeaways from the ADSCC bone marrow and cellular therapy congress 2024Gisela Maria Suárez Formigo, Zaima Mazorra, Cinthia Olexen, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 31, 2013
The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantationRohtesh S Mehta, Antonio Di Stasi, Borje S Andersson, et al.
Cytotherapy|October 8, 2013
Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood engraftmentSimon N Robinson, Michael W Thomas, Paul J Simmons, et al.
British Journal of Haematology|March 16, 2017
Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myelomaNina Shah, Li Li, Jessica McCarty, et al.
Journal for Immunotherapy of Cancer|June 20, 2020
Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancerAnanth Annapragada, Andrew Sikora, Catherine Bollard, et al.
Pageof 3